Sisram Medical prices $125m IPO low

Sisram Medical, a subsidiary of Chinese conglomerate Fosun International, has raised HK$978.6m ($125m) from its spin off in Hong Kong, pricing the IPO at the bottom of guidance.

  • By Jonathan Breen
  • 12 Sep 2017


The Israel-based medical equipment manufacturer closed books on Monday with enough demand to cover its offer of 110m shares — 80% of which was primary stock. Allocations were still taking place as of Tuesday afternoon in Hong Kong, and were expected to wrap up by the evening.

Most ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Panda Bonds Top Arrangers

Rank Arranger Share % by Volume
1 Bank of China (BOC) 28.15
2 CITIC Securities 21.52
3 China CITIC Bank Corp 9.93
4 China Merchants Bank Co 9.38
5 Industrial and Commercial Bank of China (ICBC) 7.73

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 CITIC Securities 13,827.70 78 5.93%
2 UBS 13,644.76 81 5.86%
3 Goldman Sachs 10,607.81 53 4.55%
4 Morgan Stanley 9,964.98 53 4.28%
5 China Securities Co Ltd 9,861.82 46 4.23%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 31,212.38 211 8.11%
2 Citi 29,616.03 180 7.69%
3 JPMorgan 23,422.21 136 6.08%
4 Bank of America Merrill Lynch 19,805.99 103 5.14%
5 Standard Chartered Bank 16,034.80 121 4.16%

Asian polls & awards